digital currency trader Related searches

Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.State Financial Supervision and Administration: Actively guide banks and insurance institutions to reduce costs and increase efficiency, and broaden capital replenishment channels. On December 13, the Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference, and to study and deploy implementation measures in light of the requirements of the National Financial System Work Conference. The meeting called for promoting the high-quality development of the banking and insurance industry, actively guiding banking and insurance institutions to reduce costs and increase efficiency, broadening capital replenishment channels, and improving sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Guangzhou Institute: Make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. With the rapid development of polysilicon industry, the relationship between supply and demand changes rapidly and the price fluctuates greatly due to various factors such as industrial policy, production cycle and technological progress. Due to the lack of objective and continuous price signals, the polysilicon industry has concentrated capacity investment and construction, which is prone to problems such as staged supply and demand mismatch, which is not conducive to the healthy and stable development of the industry. In this context, photovoltaic industry chain enterprises have increasingly strong demands for listed polysilicon futures, pricing with futures tools and managing risks. At the same time, the listed polysilicon futures will help to export the international pricing benchmark, form the "China" price of polysilicon international trade reflecting China's industrial volume, and gradually enhance China's influence in polysilicon international trade pricing. The insiders believe that at present, the industrial silicon varieties in Guangzhou have been running smoothly for nearly two years, and the listing of polysilicon varieties will further improve the variety layout of the crystalline silicon industrial chain for futures services, and provide more accurate futures tools for polysilicon and its downstream photovoltaic industrial chain, which is conducive to further consolidating the global competitive advantage of China's photovoltaic and other industries. The relevant person in charge of the Guangzhou Stock Exchange said that in the next step, under the guidance of the China Securities Regulatory Commission, the Guangzhou Stock Exchange will make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. (Guangzhou Institute)

Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Canada recorded a monthly wholesale sales rate of 1% in October, the largest increase since April 2024. Canada recorded a monthly wholesale sales rate of 1% in October, with an expected 0.5% and a previous value of 0.80%. Canada's annual wholesale sales rate in October was 1.7%, and the previous value was -0.4%. Canada's annual wholesale inventory rate in October was -1%, and the previous value was 0.7%. The monthly rate of wholesale inventory in Canada in October was 0.9%, and the previous value was 0.2%. The monthly inventory rate of manufacturing industry in Canada in October was 0.2%, and the previous value was -0.4%. The monthly rate of new manufacturing orders in Canada in October was -0.9%, and the previous value was 3.9%. The monthly rate of unfinished orders in Canada's manufacturing industry in October was -0.2%, and the previous value was 1.6%. Canada's capacity utilization rate in the third quarter was 79.3%, with an expected 78.9% and a previous value of 79.10%. Canada's manufacturing inventory shipment ratio in October was 1.69%, and the previous value was 1.74%.Analysis: the potential weakness of Canada's manufacturing industry still exists. Forexlive: Canada's manufacturing industry rebounded strongly, mainly driven by petroleum products and automobiles. However, the year-on-year data decline shows that some potential weakness still exists.

Market news: Hungary and Bulgaria find solutions for Russian natural gas transportation.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.Ningbo Shipping Exchange: The freight rate of the United States and the West increased sharply, and the comprehensive index stopped falling and rose. This week, the Ningbo Export Container Freight Index (NCFI) of the Maritime Silk Road Index released by Ningbo Shipping Exchange closed at 1722.8 points, up 4.8% from last week. Among the 21 routes, the freight index of 7 routes rose and that of 14 routes fell. Among the major ports along the "Maritime Silk Road", the freight index of 4 ports rose and that of 12 ports fell. The overall shipment of the market has increased, liner companies have reduced their route capacity, and at the same time, they have adjusted the port-calling order of some routes in the west of the United States, and the freight rate has increased more than that in the east of the United States. The freight index of the US-East route was 1808.1 points, up 10.0% from last week. The freight index of the US-West route was 2092.1 points, up 43.5% from last week.